Disruption of Dopamine Homeostasis Associated with Alteration of Proteins in Synaptic Vesicles: A Putative Central Mechanism of Parkinson's Disease Pathogenesis
- PMID: 37815908
- PMCID: PMC11081171
- DOI: 10.14336/AD.2023.0821-2
Disruption of Dopamine Homeostasis Associated with Alteration of Proteins in Synaptic Vesicles: A Putative Central Mechanism of Parkinson's Disease Pathogenesis
Abstract
Vestigial dopaminergic cells in PD have selectivity for a sub-class of hypersensitive neurons with the nigrostriatal dopamine (DA) tract. DA is modulated in pre-synaptic nerve terminals to remain stable. To be specific, proteins at DA release sites that have a function of synthesizing and packing DA in cytoplasm, modulating release and reingestion, and changing excitability of neurons, display regional discrepancies that uncover relevancy of the observed sensitivity to neurodegenerative changes. Although the reasons of a majority of PD cases are still indistinct, heredity and environment are known to us to make significant influences. For decades, genetic analysis of PD patients with heredity in family have promoted our comprehension of pathogenesis to a great extent, which reveals correlative mechanisms including oxidative stress, abnormal protein homeostasis and mitochondrial dysfunction. In this review, we review the constitution of presynaptic vesicle related to DA homeostasis and describe the genetic and environmental evidence of presynaptic dysfunction that increase risky possibility of PD concerning intracellular vesicle transmission and their functional outcomes. We summarize alterations in synaptic vesicular proteins with great involvement in the reasons of some DA neurons highly vulnerable to neurodegenerative changes. We generalize different potential targets and therapeutic strategies for different pathogenic mechanisms, providing a reference for further studies of PD treatment in the future. But it remains to be further researched on this recently discovered and converging mechanism of vesicular dynamics and PD, which will provide a more profound comprehension and put up with new therapeutic tactics for PD patients.
Conflict of interest statement
The authors declare that they have no competing interest.
Figures
Similar articles
-
Synaptic dysfunction in Parkinson's disease.Adv Exp Med Biol. 2012;970:553-72. doi: 10.1007/978-3-7091-0932-8_24. Adv Exp Med Biol. 2012. PMID: 22351072 Review.
-
Vesicular integrity in Parkinson's disease.Curr Neurol Neurosci Rep. 2013 Jul;13(7):362. doi: 10.1007/s11910-013-0362-3. Curr Neurol Neurosci Rep. 2013. PMID: 23690026 Free PMC article. Review.
-
Converging roles of ion channels, calcium, metabolic stress, and activity pattern of Substantia nigra dopaminergic neurons in health and Parkinson's disease.J Neurochem. 2016 Oct;139 Suppl 1(Suppl Suppl 1):156-178. doi: 10.1111/jnc.13572. Epub 2016 Mar 23. J Neurochem. 2016. PMID: 26865375 Free PMC article. Review.
-
LRRK2 phosphorylation of auxilin mediates synaptic defects in dopaminergic neurons from patients with Parkinson's disease.Proc Natl Acad Sci U S A. 2018 May 22;115(21):5576-5581. doi: 10.1073/pnas.1717590115. Epub 2018 May 7. Proc Natl Acad Sci U S A. 2018. PMID: 29735704 Free PMC article.
-
Functional enhancement and protection of dopaminergic terminals by RAB3B overexpression.Proc Natl Acad Sci U S A. 2009 Dec 29;106(52):22474-9. doi: 10.1073/pnas.0912193106. Epub 2009 Dec 10. Proc Natl Acad Sci U S A. 2009. PMID: 20007772 Free PMC article.
Cited by
-
Advancing Neurological Health: Insights into Aging, Immunity, and Vascular Dynamics.Aging Dis. 2024 May 7;15(3):939-944. doi: 10.14336/AD.2024.0423. Aging Dis. 2024. PMID: 38722789 Free PMC article.
-
Meta-analysis and in-silico functional characterization of the SNCA variant rs356220 in Parkinson's disease.Sci Rep. 2025 Jul 2;15(1):23358. doi: 10.1038/s41598-025-04435-0. Sci Rep. 2025. PMID: 40603942 Free PMC article.
References
-
- Barnett R (2016). Parkinson's disease. Lancet, 387:217. - PubMed
-
- Lazzeri G, Lenzi P, Busceti CL, Ferrucci M, Falleni A, Bruno V, et al.. (2007). Mechanisms involved in the formation of dopamine-induced intracellular bodies within striatal neurons. J Neurochem, 101:1414-1427. - PubMed
-
- Pasquali L, Lazzeri G, Isidoro C, Ruggieri S, Paparelli A, Fornai F (2008). Role of autophagy during methamphetamine neurotoxicity. Ann N Y Acad Sci, 1139:191-196. - PubMed
-
- Sossi V, de la Fuente-Fernandez R, Nandhagopal R, Schulzer M, McKenzie J, Ruth TJ, et al.. (2010). Dopamine turnover increases in asymptomatic LRRK2 mutations carriers. Mov Disord, 25:2717-2723. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical